Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Moodys
Covington
Boehringer Ingelheim
US Army
Johnson and Johnson

Generated: July 15, 2019

DrugPatentWatch Database Preview

Litigation Details for Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC (D. Del. 2018)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC (D. Del. 2018)

Docket ➤ Sign Up Date Filed 2018-09-20
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm F. Connolly
Jury Demand Plaintiff Referred To
Parties EAGLE PHARMACEUTICALS, INC.; SLAYBACK PHARMA LLC
Patents 10,010,533; 8,609,707; 9,265,831; 9,572,796; 9,572,797
Attorneys Daniel G. Brown; Eve H. Ormerod; James P. Barabas; John W. Shaw; Karen Elizabeth Keller; Kenneth G. Schuler; Marc N. Zubick; Michelle L. Ernst; Nathan Roger Hoeschen; Neal C. Belgam
Firms Shaw Keller LLP; Smith, Katzenstein, & Jenkins LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC
The small molecule drug covered by the patents cited in this case is ➤ Sign Up .

Details for Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 (“the ’796 patent”); 9,572,797 (“the ’797 patent”); and 10,010,533 (“the ’533 patent”) (collectively,…COUNT V – INFRINGEMENT OF U.S. PATENT NO. 10,010,533 UNDER 35 U.S.C. § 271(e)(2)… INFRINGEMENT OF U.S. PATENT NO. 10,010,533 119. Eagle incorporates…of the ’707 patent, the ’831 patent, the ’796 patent, the ’797 patent, and the ’533 patent. …Plaintiff’s U.S. Patent Nos. 8,609,707 (“the ’707 patent”); 9,265,831 (“the ’831 patent”); 9,572,796 (“ External link to document
0000-00-00 3 ,831 B2; US 9,572,796 B2; US 9,572,797 B2; US 10,010,533 B2. (crb) (Entered: 09/21/2018) 20 September… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,609,707 B2…20 September 2018 1:18-cv-01459 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Accenture
Teva
UBS
McKinsey
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.